Aethlon Medical, Inc. (NASDAQ:AEMD – Get Free Report) was the recipient of a significant drop in short interest during the month of August. As of August 31st, there was short interest totalling 104,400 shares, a drop of 57.9% from the August 15th total of 247,800 shares. Based on an average daily volume of 292,800 shares, the short-interest ratio is presently 0.4 days.
Analyst Ratings Changes
Separately, StockNews.com assumed coverage on shares of Aethlon Medical in a research report on Saturday, September 9th. They set a “sell” rating for the company.
Aethlon Medical Price Performance
Aethlon Medical (NASDAQ:AEMD – Get Free Report) last announced its quarterly earnings results on Thursday, August 10th. The medical equipment provider reported ($0.13) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.01). During the same quarter last year, the business posted ($0.19) EPS. As a group, sell-side analysts expect that Aethlon Medical will post -0.52 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently made changes to their positions in the business. Vanguard Group Inc. boosted its stake in shares of Aethlon Medical by 112.9% in the third quarter. Vanguard Group Inc. now owns 1,053,198 shares of the medical equipment provider’s stock valued at $613,000 after purchasing an additional 558,596 shares during the period. Renaissance Technologies LLC boosted its stake in shares of Aethlon Medical by 11.6% in the first quarter. Renaissance Technologies LLC now owns 270,297 shares of the medical equipment provider’s stock valued at $395,000 after purchasing an additional 28,097 shares during the period. Jane Street Group LLC boosted its stake in shares of Aethlon Medical by 895.7% in the fourth quarter. Jane Street Group LLC now owns 140,245 shares of the medical equipment provider’s stock valued at $39,000 after purchasing an additional 126,160 shares during the period. Two Sigma Investments LP boosted its stake in shares of Aethlon Medical by 219.3% in the first quarter. Two Sigma Investments LP now owns 127,341 shares of the medical equipment provider’s stock valued at $49,000 after purchasing an additional 87,458 shares during the period. Finally, Citadel Advisors LLC purchased a new position in shares of Aethlon Medical in the third quarter valued at approximately $72,000. Hedge funds and other institutional investors own 3.02% of the company’s stock.
Aethlon Medical Company Profile
Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system.
- Five stocks we like better than Aethlon Medical
- Are Stock Buybacks Good for the Average Investor?
- Is Enbridge Stock Too Cheap to Pass Up Now?
- How is Compound Interest Calculated?
- 5 Best REIT Alternatives for Passive Real Estate Income
- Health Care Stocks Explained: Why You Might Want to Invest
- 5 Reasons Kroger Should Be On Every Income Investor Watchlist
Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with MarketBeat.com's FREE daily email newsletter.